rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Phil M. Holzer

SVP and Controller

Company insider

Files Form 4 as: SVP and Controller, Bristol-Myers Squibb.

Every Form 4 they filed

In numbers

Trades disclosed
65
Buys
0
Sells
2
Bought
$0
Sold
$106K
Companies
1
Companies where not an officer
0
First trade
10 Mar 2024
Last trade
25 Aug 2026
Last filed
26 Aug 2026

Companies traded

Where they are an officer
BMY Bristol-Myers SquibbOfficer · Pharmaceuticals · last 25 Aug 20260 buys · 2 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
25 Aug 2026filed 26 Aug 2026BMY Bristol-Myers SquibbPharmaceuticalsSEC FORM 4 Sold$34K500 at $67.50filing
25 Aug 2026filed 26 Aug 2026BMY Bristol-Myers SquibbPharmaceuticalsSEC FORM 4 Sold$34K500 at $67.50filing
10 Mar 2026filed 12 Mar 2026BMY Bristol-Myers SquibbPharmaceuticalsSEC FORM 4 Code M—811 at $0.00filing
10 Mar 2026filed 12 Mar 2026BMY Bristol-Myers Squibboption or derivative · PharmaceuticalsSEC FORM 4 Code M—811 at $0.00filing
10 Mar 2026filed 12 Mar 2026BMY Bristol-Myers Squibboption or derivative · PharmaceuticalsSEC FORM 4 Code M—768 at $0.00filing
10 Mar 2026filed 12 Mar 2026BMY Bristol-Myers Squibboption or derivative · PharmaceuticalsSEC FORM 4 Code M—4,612 at $0.00filing
10 Mar 2026filed 12 Mar 2026BMY Bristol-Myers Squibboption or derivative · PharmaceuticalsSEC FORM 4 Code A—5,031 at $0.00filing
10 Mar 2026filed 12 Mar 2026BMY Bristol-Myers Squibboption or derivative · PharmaceuticalsSEC FORM 4 Code A—7,547 at $0.00filing
10 Mar 2026filed 12 Mar 2026BMY Bristol-Myers SquibbPharmaceuticalsSEC FORM 4 Code J—91 at $0.00filing
10 Mar 2026filed 12 Mar 2026BMY Bristol-Myers SquibbPharmaceuticalsSEC FORM 4 Code F$16K261 at $60.13filing
10 Mar 2026filed 12 Mar 2026BMY Bristol-Myers Squibboption or derivative · PharmaceuticalsSEC FORM 4 Code M—811 at $0.00filing
10 Mar 2026filed 12 Mar 2026BMY Bristol-Myers Squibboption or derivative · PharmaceuticalsSEC FORM 4 Code M—768 at $0.00filing
10 Mar 2026filed 12 Mar 2026BMY Bristol-Myers Squibboption or derivative · PharmaceuticalsSEC FORM 4 Code M—4,612 at $0.00filing
10 Mar 2026filed 12 Mar 2026BMY Bristol-Myers Squibboption or derivative · PharmaceuticalsSEC FORM 4 Code A—5,031 at $0.00filing
10 Mar 2026filed 12 Mar 2026BMY Bristol-Myers Squibboption or derivative · PharmaceuticalsSEC FORM 4 Code A—7,547 at $0.00filing
10 Mar 2026filed 12 Mar 2026BMY Bristol-Myers SquibbPharmaceuticalsSEC FORM 4 Code M—768 at $0.00filing
10 Mar 2026filed 12 Mar 2026BMY Bristol-Myers SquibbPharmaceuticalsSEC FORM 4 Code J—83 at $0.00filing
10 Mar 2026filed 12 Mar 2026BMY Bristol-Myers SquibbPharmaceuticalsSEC FORM 4 Code F$15K248 at $60.13filing
10 Mar 2026filed 12 Mar 2026BMY Bristol-Myers SquibbPharmaceuticalsSEC FORM 4 Code M—4,612 at $0.00filing
10 Mar 2026filed 12 Mar 2026BMY Bristol-Myers SquibbPharmaceuticalsSEC FORM 4 Code J—2,264 at $0.00filing

Sectors

Health Care2

Buys in green, sells in red, by the company’s sector.

Related people

Cari GallmanEVP, General Counsel · EVP, General Counsel at Bristol Myers Squibb Co, filing Form 4 there in the last year
Theodore R. Samuels IIDirector · Director at Bristol Myers Squibb Co, filing Form 4 there in the last year
Peter J. ArduiniDirector · Director at Bristol Myers Squibb Co, filing Form 4 there in the last year
Derica W. RiceDirector · Director at Bristol Myers Squibb Co, filing Form 4 there in the last year
Phyllis R. YaleDirector · Director at Bristol Myers Squibb Co, filing Form 4 there in the last year
Cristian MassacesiEVP,Chief Med Offr,Head of Dev · Also traded BMY in the last 90 days